Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said Friday.
Dec 1, 2023
0
0
Ahead of the winter respiratory virus season, many parents were relieved the U.S. Food and Drug Administration approved a shot to combat respiratory syncytial virus, or RSV, for infants and toddlers this summer.
Nov 24, 2023
0
0
Over a third of American adults are worried that they or someone in their family will get the seasonal flu, COVID-19, or RSV (respiratory syncytial virus) in the next three months, according to a new health survey from the ...
Nov 20, 2023
0
1
Respiratory syncytial virus (RSV) is a common virus that seriously affects vulnerable populations such as infants, young children and older adults. Dr. Wasem Alsabbagh, associate professor at the University of Waterloo School ...
Nov 20, 2023
0
1
RSV infections are rising sharply in some parts of the country, nearly filling hospital emergency departments in Georgia, Texas and some other states.
Nov 17, 2023
0
0
To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.
Nov 16, 2023
0
0
A RSV new therapy for infants, called nirsevimab, started shipping in September. By mid-October, demand for nirsevimab, sold under the brand name Beyfortus, had already outstripped supply, according to the pharmaceutical ...
Nov 13, 2023
0
0
The world is entering a new era of vaccines. Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.
Oct 30, 2023
0
0
Researchers from Karolinska Institutet, among others, have developed a prognostic model that identifies the children most at risk of severe RSV infection. The study, published in The Lancet Digital Health, can show which ...
Oct 26, 2023
0
26
Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants.
Oct 24, 2023
0
0
